Objective:

To address fragmented services and rising demand for allergy care in the UK, driven by increased prevalence and awareness.

Key Findings:

• One in three people in the UK is affected by allergic disease.
• Allergy accounts for around 6% of GP visits and 10% of the GP prescribing budget.
• The prevalence of allergic rhinitis and eczema has trebled since the 1970s.
• Hospital admissions for anaphylaxis increased threefold from 1998 to 2018.
• The UK has one of the worst allergy rates in the world.

Interpretation:

The strategy aims to establish allergy as a major chronic condition in health policy, improve care consistency across various sectors, and address health inequalities.

Limitations:

• Inconsistent care pathways and limited specialist capacity.
• Gaps in data and surveillance hinder effective implementation.
• Need for better coordination across sectors.

Conclusion:

The launch marks the beginning of a broader program to translate evidence into measurable improvements in allergy care across the UK, with a focus on health inequalities and workforce sustainability.